| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Aug―11 |
“Status of Evidence on Efficacy and Safety of Indian Traditional Medicine (AYUSH) for COVID-19: Protocol for a Country-specific Qualitative Review and Evidence Map Synthesis” |
Azeem Ahmad, Manohar S. Gundeti, Meena R, Eugene Wilson, Malik Itrat, Ghazala Javed, et al. (+10) Mohd Aleemuddin Quamri, Deepti Singh Chalia, Pooja Yadav, Athul T P, Karthik K P, Anjana C S, Mythri H S, Aparna Dileep, Shifa Shetty P, Galib R |
| 2 |
[GO] |
2025―Jul―28 |
Andrographis paniculata or Favipiravir in Mild COVID-19: A Randomized Control Trial |
Rujipas Sirijatuphat, Navin Horthongkham, Chutikarn Chaimayo, Patimaporn Wongprompitak, Wuttikrai Kongsankum, Phornnapa Charoenkij, et al. (+7) Titchaphorn Palo, Suthathip Mahajaronesiri, Nalinthika Nathananwanit, Sansanee Senawong, Wannee Kantakamalakul, Pravit Akarasereenont, Chairat Permpikul |
| 3 |
[GO] |
2025―Jul―26 |
Potential of diterpenoid andrographolide in COVID-19 therapy: an insight on its antiviral-, immunomodulatory-, anti-inflammatory-, antioxidant- and antithrombotic- properties |
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, Bishu Karmakar |
| 4 |
[GO] |
2025―Jul―25 |
Comprehensive insights into the therapeutic effects of baicalein and baicalin against SARS-COV-2 infection |
Cheng-Han Lin, Meng-Wei Lin, Hua-Hsin Chiang, Ting-Hsuan Wu, Chin-Hung Tsai, Chih-Sheng Lin |
| 5 |
[GO] |
2024―Dez―03 |
Exploring the antimicrobial and antioxidative potential of Leucas aspera (Willd.) Link: Phytochemical screening, molecular docking, and HR-LC/MS profiling against SARS-CoV-2 protein 3CLPro, Spike and RDB |
T.S Shalini, Prathiviraj Ragothaman, P Senthilraja |
| 6 |
[GO] |
2024―Dez―02 |
Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 Spike Proteins with human ACE2 receptor |
Acharya Balkrishna, Rishabh Dev, Sandeep Kumar, Anurag Varshney |
| 7 |
[GO] |
2024―Apr―16 |
In vitro study on the inhibitory effect of various essential oils against murine coronavirus mouse hepatitis virus A-59 replication |
Karelle Contant, Shiv Shankar, Monique Lacroix |
| 8 |
[GO] |
2024―Feb―03 |
Potential benefits and challenges on the use of phytochemicals for obese COVID-19 patients: A review |
Murtala Bello Abubakar, Abdurrahman Pharmacy Yusuf, Dawoud Usman, Ibrahim Babangida Abubakar, Babangida Sanusi Katsayal, Idris Zubairu Sadiq, et al. (+5) Shehu Muhammad Hassan, Gilead Ebiegberi Forcados, Kasimu Ghandi Ibrahim, Shuaibu Hudu Abdullahi, Aliyu Muhammad |
| 9 |
[GO] |
2023―Nov―18 |
Review on the secondary metabolites, biological properties, and ethnomedicinal uses of the component species of the Buheri wa Afya formula used to treat COVID-19 in Tanzania |
John J. Makangara, Anthony M. Mshandete, Ernest R. Mbega, John R. Nyika, Frank Mbago, Edward G. Ndilanha, et al. (+2) Raphael J. Nyika, Joseph J. Nyika |
| 10 |
[GO] |
2023―Okt―15 |
Iran's commercial herbal products for managing COVID-19: A review based on clinical trial-based approach |
Vahideh Ahmadpour, Saba Rahimi Bahoosh, Parvin Jahanbani, Mahdieh Eftekhari |
| 11 |
[GO] |
2023―Mrz―11 |
Effects of diarylbutane lignans from Schisandra chinensis fruit on SARS-CoV-2 3CLpro and PLpro and their in vitro anti-inflammatory properties |
Bin Li, Liansheng Qiao, Qi Xiao, Jianuo Zhang, Jiushi Liu, Bengang Zhang, Haitao Liu |
| 12 |
[GO] |
2022―Dez―30 |
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: major interactions with host/virus proteases |
Biswanath Dinda, Subhajit Dinda, Manikarna Dinda |
| 13 |
[GO] |
2022―Dez―20 |
A randomized controlled pilot study of add-on therapy of CIM-MEG19 (standardized Andrographis paniculata formulation) in mild to moderate COVID-19 |
Karuna Shanker, Hrishikesh Rangnekar, Asmita Wele, Pravin Soni, Pranesh Gaikwad, Anirban Pal, et al. (+2) Dnyaneshwar U. Bawankule, Debabrata Chanda |
| 14 |
[GO] |
2022―Apr―20 |
Ayurvedic formulations: potential COVID-19 therapeutics? |
Anees Ahmed Mahaboob Ali, Andrea Bugarcic, Nenad Naumovski, Reena Ghildyal |
| 15 |
[GO] |
2022―Apr―18 |
Herbal medications and natural products for patients with covid-19 and diabetes mellitus: potentials and challenges |
Abdurrahman Pharmacy Yusuf, Jian-ye Zhang, Jing-quan Li, Aliyu Muhammad, Murtala Bello Abubakar |
| 16 |
[GO] |
2022―Mrz―04 |
Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking |
Junfeng Cao, Lianglei Li, Li Xiong, Chaochao Wang, Yijun Chen, Xiao Zhang |
| 17 |
[GO] |
2022―Feb―12 |
Molecular and structural insights of β-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors |
Syeda Warisul Fatima, Shahenvaz Alam, Sunil K. Khare |
| 18 |
[GO] |
2022―Feb―08 |
Effects of theaflavin-gallate in-silico binding with different proteins of SARS-CoV-2 and host inflammation and vasoregulations referring an experimental rat-lung injury. |
Dr. Smarajit Maiti, Assistant Professor Dr. Amrita Banerjee, Mehak Kanwar |
| 19 |
[GO] |
2021―Sep―29 |
Computational screening of phytochemicals from three medicinal plants as inhibitors of transmembrane protease serine 2 implicated in SARS-CoV-2 infection |
Omotayo O. Oyedara, Joseph M. Agbedahunsi, Folasade M. Adeyemi, Alfredo Juárez-Saldivar, Olatomide A. Fadare, Charles O. Adetunji, Gildardo Rivera |
| 20 |
[GO] |
2021―Jul―13 |
Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2 |
Rupesh V. Chikhale, Saurabh K. Sinha, Pukar Khanal, Nilambari S. Gurav, Muniappan Ayyanar, Satyendra K. Prasad, et al. (+3) Manish M. Wanjari, Rajesh B. Patil, Shailendra S. Gurav |
| 21 |
[GO] |
2021―Jun―06 |
Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: in silico study |
Nitish Kumar, Atamjit Singh, Harmandeep Kaur Gulati, Kavita Bhagat, Komalpreet Kaur, Jaspreet Kaur, et al. (+6) Shilpa dudhal, Amit Duggal, Puja Gulati, Harbinder Singh, Jatinder Vir Singh, Preet Mohinder Singh Bedi |
| 22 |
[GO] |
2021―Mrz―20 |
The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19 |
Jin A. Shin, Subin Oh, Jong-Moon Jeong |
| 23 |
[GO] |
2021―Feb―17 |
The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions |
Adel A. Gomaa, Yasmin A. Abdel-Wadood |
| 24 |
[GO] |
2021―Jan―18 |
Insights into Forsythia Honeysuckle (Lianhuaqingwen) Capsules: A Chinese Herbal Medicine Repurposed for COVID-19 Pandemic |
Chengyuan Liang, Nan Hui, Yuzhi Liu, Guaiping Qiao, Juan Li, Lei Tian, et al. (+7) Xingke Ju, Minyi Jia, Hong Liu, Wenqiang Cao, Pengcheng Yu, Han Li, Xiaodong Ren |
| 25 |
[GO] |
2020―Dez―31 |
SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: An in silico study |
Fai-Chu Wong, Joe-Hui Ong, Tsun-Thai Chai |
| 26 |
[GO] |
2020―Nov―27 |
nnNature's therapy for COVID-19: Targeting the vital Non-Structural Proteins (NSP) from SARS-CoV-2 with phytochemicals from Indian medicinal plants |
Pratap Kumar Parida, Dipak Paul, Debamitra Chakravorty |
